
Brazil Aesthetic Devices Market Analysis by Mordor Intelligence
The Brazil Aesthetic Devices Market size is projected to expand from USD 196.89 million in 2025 and USD 213.51 million in 2026 to USD 345.05 million by 2031, registering a CAGR of 10.08% between 2026 to 2031.
Rapid uptake of minimally and non-invasive procedures, a broadening practitioner base that now includes dentists and general practitioners, and faster ANVISA approvals are accelerating sales of injectables and energy-based platforms. Device demand is also buoyed by a sharp rise in obesity, social-media-driven beauty norms, and private-equity-funded franchise models that lower entry barriers for new clinics. At the same time, elevated SELIC rates, a weaker Brazilian real, and sporadic enforcement against grey-market imports create cost headwinds that favor companies with strong balance sheets and compliant portfolios. Competitive intensity is increasing as South Korean and U.S. manufacturers acquire local distributors or sign exclusive partnerships, signaling that the Brazil aesthetic devices market is becoming a regional launch pad rather than a stand-alone destination.
Key Report Takeaways
- By device type, non-energy devices dominated with 81.42% share of the Brazil aesthetic devices market in 2025, while energy-based platforms are projected to grow fastest at a 13.43% CAGR through 2031.
- By application, skin resurfacing and tightening led with 27.45% revenue share in 2025, whereas body contouring and cellulite reduction are forecast to expand at a 14.67% CAGR through 2031.
- By end user, hospitals and surgical centers captured 39.63% share in 2025, but medical spas and beauty centers are advancing at a 13.42% CAGR over the forecast period.
- By gender, female patients accounted for 76.24% of total procedures in 2025, yet male treatments are increasing at a 12.77% CAGR through 2031.
- By age group, individuals aged 35–50 years held 44.13% share in 2025, while the 18–34 cohort is on track to grow at a 13.82% CAGR during 2026–2031.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.
Brazil Aesthetic Devices Market Trends and Insights
Drivers Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rapid Uptake of Minimally & Non-Invasive Procedures | +2.5% | São Paulo, Rio de Janeiro, Brasília | Medium term (2-4 years) |
| Growing Social-Media-Driven Beauty Consciousness | +1.8% | Urban centers with high Instagram/TikTok penetration | Short term (≤ 2 years) |
| Ageing & Obesity Trends Driving Body Contouring | +2.2% | Southeast and South regions | Long term (≥ 4 years) |
| Device Miniaturization Spurring Home-Use Segment | +1.0% | Affluent urban households | Medium term (2-4 years) |
| ANVISA Fast-Track Approvals (RDC 751/2022) | +1.5% | Nationwide | Short term (≤ 2 years) |
| Venture-Capital Inflow to Local OEMs | +0.8% | São Paulo, Rio de Janeiro | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Rapid Uptake of Minimally & Non-Invasive Procedures
Brazil performed 3.1 million aesthetic procedures in 2024—2.35 million surgical and 769,000 non-surgical—making it one of the top five countries worldwide.[1] ISAPS Staff, “2024 Global Survey Results,” International Society of Aesthetic Plastic Surgery, isaps.org Non-surgical demand is expanding faster because treatments such as botulinum toxin and hyaluronic-acid fillers require no anesthesia, create little downtime, and can be administered in dentist offices that already own laser or radiofrequency systems. Dentists executed 43% of clinic-based procedures in 2024 and 87% of total applications, effectively bypassing dermatology bottlenecks and shortening the device-adoption cycle.[2]Bruno Freitas, “Dentists’ Participation in Aesthetic Procedures in Brazil,” Revista Brasileira de Odontologia, scielo.br Franchise operators amplify this reach; JL Health alone supplies 18 equipment brands and expects revenue to reach BRL 700 million in 2024. By widening the practitioner base, these dynamics add 2.5 percentage points to the overall CAGR of the Brazil aesthetic devices market.
Growing Social-Media-Driven Beauty Consciousness
A Croma survey published in 2024 found that 72% of Brazilian men care about their looks and 68% openly discuss it, while Instagram and TikTok have become discovery engines for “before-after” content. Academic work confirms a causal link between social-media exposure and willingness to undergo procedures.[3] Fernanda Silva, “Social Media Exposure and Intent to Undergo Aesthetic Procedures,” International Journal of Environmental Research and Public Health, mdpi.com Clinics package multi-modality treatments such as the “Sleeping Beauty” combo of botulinum toxin plus JetPeel for viral storytelling, pulling younger patients into routine maintenance programs. This cultural shift is especially potent among 18-34-year-olds, who are growing at a 13.82% CAGR, and it lifts the market trajectory by roughly 1.8 percentage points.
Ageing & Obesity Trends Driving Body Contouring Demand
Obesity prevalence climbed from 14.5% in 2008 to 32.9% in 2021 and could hit 45.5% by 2030. Meanwhile, the share of Brazilians over 65 is on track to reach 17% by 2042. These twin demographics fuel demand for cryolipolysis, radiofrequency, and high-intensity-focused ultrasound (HIFU) treatments that offer fat reduction with minimal downtime. Brazilian studies have already validated 1470 nm endolaser techniques for localized adiposity, and micro-focused ultrasound trials report measurable collagen remodeling without surgery. Together they add an estimated 2.2 percentage points to the CAGR of the Brazil aesthetic devices market.
Device Miniaturization Spurring Home-Use Segment
Shrinking laser diodes and RF generators allow brands to pack clinical technology into handheld gadgets priced at USD 200-500. Portable IPL hair-removal devices and RF skin-tightening wands now populate Brazilian e-commerce platforms, targeting affluent urban households as an at-home bridge between clinic visits. JL Health is testing consumer sub-brands to capture recurring revenue from cartridge refills and RF gel packs. Although the category is small today, it adds roughly 1 percentage point to the market CAGR and offers manufacturers a hedge against clinic-channel saturation.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High Cap-Ex for Advanced Platforms | -1.5% | Smaller cities and solo practices | Medium term (2-4 years) |
| Practitioner-Training Gaps & Safety Incidents | -1.2% | Nationwide, higher in non-metro areas | Short term (≤ 2 years) |
| Economic Volatility Hitting Discretionary Spend | -2.0% | Lower-income households nationwide | Short term (≤ 2 years) |
| Grey-Market Device Imports | -0.8% | Border states and online channels | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
High Cap-Ex for Advanced Platforms
Fractional CO₂ lasers, hybrid HIFU/RF consoles, and picosecond tattoo-removal systems cost between BRL 200,000 and BRL 1.3 million, a steep hurdle for independent clinics. With real interest rates hovering near 10% after the SELIC peaked at 14.75% in 2025, equipment leases erode profitability and delay technology upgrades. A 22% depreciation of the real in 2024 also inflated import prices. The resulting cap-ex drag trims about 1.5 percentage points off CAGR.
Practitioner-Training Gaps & Safety Incidents
Narrative reviews in Anais Brasileiros de Dermatologia link poor anatomical knowledge to vascular occlusion, blindness, and strokes after filler injections. Dentists handle 87% of aesthetic injectables yet often lack structured facial-danger-zone training. Proposed legislation mandating adverse-event reporting remains stalled, keeping true complication rates opaque. High-profile mishaps spark negative media cycles that shave 1.2 percentage points from short-term growth.
Segment Analysis
By Device Type: Non-Energy Dominates, Energy Platforms Accelerate
Non-energy products represented 81.42% of the Brazil aesthetic devices market in 2025, led by 121 ANVISA-approved hyaluronic-acid fillers that generate repeat sales without large capital outlays. Allergan’s HArmonyCa hybrid and Merz’s Radiesse add collagen-stimulating options that increase procedure frequency among millennials seeking “pre-juvenation.” Implants remain a smaller category but benefit from Silimed’s 12,000 m² factory that supplies domestic clinics and exports to Mercosur neighbors.
Energy-based systems—lasers, RF, IPL, and HIFU—captured 18.58% in 2025 and will grow at a 13.43% CAGR, pushing the segment’s Brazil aesthetic devices market size above USD 90 million by 2031. Clinical studies show that 1470 nm diode endolaser reduces subcutaneous fat while tightening skin, and BTL’s Emsculpt Neo has logged 55,000 Brazilian treatments that combine RF lipolysis and electromagnetic muscle stimulation. Classys’ acquisition of JL Health provides a direct path to market for the Shurink Universe HIFU system, intensifying competition against Ultherapy and Ultraformer.

By Application: Body Contouring Momentum Builds
Skin resurfacing and tightening accounted for 27.45% of 2025 revenue, thanks to fractional CO₂ lasers and micro-focused ultrasound that treat photodamage and laxity with minimal downtime. Hair-removal demand remains robust across diode and IPL platforms, anchored by cultural norms favoring smooth skin and falling per-session pricing.
Body-contouring revenues are poised to rise faster than any other indication, expanding at a 14.67% CAGR as obesity heads toward a 45.5% adult prevalence by 2030. Cryolipolysis, RF, and HIFU technologies appeal to both post-bariatric patients and younger consumers chasing “summer-ready” physiques. The segment could surpass 25% of the overall Brazil aesthetic devices market share by 2031 if forecast adoption rates hold.
By End User: Medical Spa Franchises Scale Quickly
Hospitals and surgical centers retained 39.63% of the Brazil aesthetic devices market size in 2025 due to their capacity to combine surgical and non-surgical offerings under one roof. Yet franchise-backed medical spas are growing 13.42% annually by leveraging group purchasing, standardized protocols, and aggressive social-media marketing.
XP’s strategic stake in JL Health links equipment sales with Vision One’s hospital network, enabling bundled procurement that squeezes out smaller distributors. Solo dermatology practices struggle to match franchise pricing, especially while SELIC hovers above 13%, raising the cost of financing for new lasers and HIFU platforms.

Note: Segment shares of all individual segments available upon report purchase
By Gender: Male Uptake Narrows the Gap
Women still represented 76.24% of procedure volume in 2025, sustained by high filler usage and female-specific indications such as intimate rejuvenation.
Male demand is expanding at 12.77% CAGR, with liposuction volumes up 46% over five years and rising interest in botulinum toxin, RF skin tightening, and Fotona laser facial harmonization. Clinics now market “Bro-Tox” and body-sculpt packages expressly to male influencers and athletes, eroding the once-wide gender gap.
By Age Group: Digital Natives Spur Preventive Care
Patients aged 35-50 held 44.13% share in 2025, anchored by corrective treatments such as deep-plane fillers and fractional resurfacing.
The 18-34 cohort is accelerating at a 13.82% CAGR, normalizing quarterly micro-botox and biostimulator boosters as routine skin maintenance. Academic evidence ties Instagram exposure to elevated procedural interest, turning first-time patients into long-term subscribers who drive repeat device utilization.

Note: Segment shares of all individual segments available upon report purchase
Geography Analysis
Brazil’s Southeast corridor—São Paulo, Rio de Janeiro, and Minas Gerais—generates more than 60% of national revenue and attracts the earliest launches of new lasers, fillers, and hybrid injectables. São Paulo alone logged 42 healthcare-sector M&A deals worth BRL 7.69 billion in 2021, confirming its status as the commercial backbone for the Brazil aesthetic devices market. Enforcement under ANVISA’s “Safe Aesthetics Operation” is most vigorous here, giving compliant clinics a marketing edge.
The South—Paraná, Santa Catarina, and Rio Grande do Sul—shows high male procedure penetration and rapid uptake of franchise medical-spa formats. Santa Catarina clinics report steady demand for facial harmonization among men in their early thirties, reflecting regional cultural openness to aesthetic intervention.
Growth frontiers include the Northeast and Central-West, where improving household incomes intersect with rising obesity and aging metrics. Nonetheless, sparse dermatologist density and limited capital access slow technology adoption relative to the coast. The North remains the most underserved; logistical obstacles and fewer accredited practitioners curtail supply, though local manufacturers such as Silimed leverage lower operating costs to ship implants region-wide.
Competitive Landscape
The Brazil aesthetic devices market hosts a mix of multinationals includes AbbVie/Allergan, Galderma, Merz, BTL, Candela, Cutera, and Lumenis and local champions such as JL Health, HTM Eletrônica, Ibramed, and Silimed. Bain-Capital-backed Classys now owns 77.5% of JL Health, turning the distributor into a forward operating base for the Shurink Universe HIFU system. XP’s BRL 225 million minority stake injects capital to push JL Health into gynecology, ophthalmology, and orthopedics while bundling device sales with Vision One hospital purchases .
Technology pipelines focus on hybrid and combination platforms: Allergan’s HArmonyCa mixes HA with CaHa microspheres; BTL’s Emsculpt Neo pairs RF lipolysis with magnetic muscle stimulation. Korean innovators Hugel and Classys differentiate through competitive pricing and robust educator networks, evidenced by Hugel’s partnership with Derma Dream to launch Letybo toxin across elite clinics in Rio and São Paulo.
ANVISA’s rigorous but transparent regulatory process, especially under RDC 751/2022, advantages firms with deep clinical dossiers. Grey-market crackdowns further tilt share toward companies that can document sterility, traceability, and post-market surveillance, setting up consolidation waves that favor players with diversified product portfolios and strong compliance teams.
Brazil Aesthetic Devices Industry Leaders
Cutera Inc.
Galderma
AbbVie (Allergan Aesthetics)
Candela Corporation
Lumenis Be Ltd
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- January 2026: The Aesthetic Society, The Aesthetic Foundation, and The American-Brazilian Aesthetic Meeting unveiled a purpose-driven partnership centered on patient safety and charitable outreach.
- January 2026: PharmaResearch signed an exclusive deal with Derma Dream to supply Rejuran polynucleotide injectables in preparation for Brazilian market entry.
- September 2025: Hugel accelerated Brazilian expansion through a distribution agreement with Derma Dream for its Letybo botulinum toxin product.
Brazil Aesthetic Devices Market Report Scope
As per the scope of the report, Aesthetic devices are tools used for non-surgical or minimally invasive cosmetic procedures to improve appearance through technologies like lasers, radiofrequency, ultrasound, and light.
The Brazil Aesthetic Devices Market Report is segmented by Device Type, Application, End User, Gender, and Age Group. By Device Type, the market is segmented into Energy-based Devices (Laser-based, Radiofrequency, IPL & Light-based, Ultrasound/HIFU) and Non-energy Devices (Dermal Fillers & Injectables, Implants, Microdermabrasion & Dermarollers). By Application, the market is segmented into Skin Resurfacing & Tightening, Hair Removal, Body Contouring & Cellulite Reduction, Facial Aesthetic Procedures, Pigmented & Vascular Lesion Treatment, and Others. By End User, the market is segmented into Dermatology and Aesthetic Clinics, Hospitals & Surgical Centers, Medical Spas & Beauty Centers, and Home‑use. By Gender, the market is segmented into Female and Male. By Age Group, the market is segmented into 18–34 Years, 35–50 Years, and Above 50 Years. Market Forecasts are Provided in Terms of Value (USD).
| Energy-based Devices | Laser-based |
| Radiofrequency | |
| IPL & Light-based | |
| Ultrasound / HIFU | |
| Non-energy Devices | Dermal Fillers & Injectables |
| Implants | |
| Microdermabrasion & Dermarollers |
| Skin Resurfacing & Tightening |
| Hair Removal |
| Body Contouring & Cellulite Reduction |
| Facial Aesthetic Procedures |
| Pigmented & Vascular Lesion Treatment |
| Others |
| Dermatology and Asthetic Clinics |
| Hospitals & Surgical Centers |
| Medical Spas & Beauty Centers |
| Home-use |
| Female |
| Male |
| 18-34 Years |
| 35-50 Years |
| Above 50 Years |
| By Device Type | Energy-based Devices | Laser-based |
| Radiofrequency | ||
| IPL & Light-based | ||
| Ultrasound / HIFU | ||
| Non-energy Devices | Dermal Fillers & Injectables | |
| Implants | ||
| Microdermabrasion & Dermarollers | ||
| By Application | Skin Resurfacing & Tightening | |
| Hair Removal | ||
| Body Contouring & Cellulite Reduction | ||
| Facial Aesthetic Procedures | ||
| Pigmented & Vascular Lesion Treatment | ||
| Others | ||
| By End User | Dermatology and Asthetic Clinics | |
| Hospitals & Surgical Centers | ||
| Medical Spas & Beauty Centers | ||
| Home-use | ||
| By Gender | Female | |
| Male | ||
| By Age Group | 18-34 Years | |
| 35-50 Years | ||
| Above 50 Years | ||
Key Questions Answered in the Report
How large is the Brazil aesthetic devices market in 2026?
It was valued at USD 213.51 million in 2026 and is projected to reach USD 345.05 million by 2031 at a 10.08% CAGR.
Which segment is growing fastest in Brazilian body-contouring treatments?
Body-contouring and cellulite-reduction devices are forecast to expand at 14.67% CAGR through 2031, outpacing all other applications.
Why are dentists important buyers of aesthetic devices in Brazil?
Dentists perform 43% of clinic-based procedures and 87% of total injectables, widening the practitioner base and accelerating equipment adoption.
How is macroeconomic volatility affecting device sales?
High SELIC rates, a weaker real, and slower GDP growth are raising financing costs and suppressing discretionary spending, cutting 2.0 percentage points from near-term CAGR.
What regulatory change is most influential for new device launches?
ANVISA’s RDC 751/2022 fast-track pathway shortens approval times by referencing FDA and CE dossiers, adding 1.5 percentage points to market CAGR in the short term.
Which companies recently made strategic moves in Brazil?
Classys bought 77.5% of JL Health to launch Shurink Universe HIFU, while Hugel partnered with Derma Dream to roll out Letybo botulinum toxin.




